From Proteomics to the Analysis of Single Protein Molecules

Area of Science:

• Biotechnology
• Analytical Chemistry
• Medical Diagnostics

Background:

• Current mass spectrometry methods lack the sensitivity for early disease detection.
• Proteomic technologies in medicine are hindered by limitations in analytical sensitivity.
• Existing bioanalytical methods have a sensitivity limit of 10^-12 M, insufficient for detecting single marker molecules.

Purpose of the Study:

• To propose a new technology for detecting single biomacromolecules (proteins) in biological samples.
• To establish a new direction for developing medical diagnostic systems.
• To address the need for highly sensitive methods in predictive medical diagnostics.

Main Methods:

• Conceptualizing a technology based on signal registration principles similar to a Geiger counter (Geiger-Müller counter).
• Developing a detector capable of registering signals from single molecules.
• Aiming for a sensitivity of 10^-18 M for single-molecule detection in microliter sample volumes.

Main Results:

• The proposed technology aims for a sensitivity of 10^-18 M, enabling single-molecule detection.
• This approach is analogous to a Geiger counter for solutions, registering a signal if at least one target molecule is present.
• The technology is designed to detect single marker molecules in 1-10 µL of biological sample volume.

Conclusions:

• The proposed Geiger counter-like technology offers a significant advancement in analytical sensitivity for medical diagnostics.
• This novel approach could revolutionize early disease detection by identifying single marker molecules.
• Achieving 10^-18 M sensitivity is crucial for predictive medical diagnostics and overcoming current proteomic limitations.